1. Vosevi is a follow-up treatment for adults with chronic hepatitis C virus genotypes 1 through 6 who have mild or no cirrhosis.
2. Nerlynx is a treatment for early-stage breast cancer patients with a HER2 genetic mutation.
3. Lusdana Nexvue is a biosimilar version of Sanofi’s diabetes drug Lantus.
4. The Embrace Neonatal MRI System is an MRI device for infants in the neonatal intensive care unit.
More articles on supply chain:
5 steps to reduce blood costs at your hospital
Bloomberg: FedEx’s TNT ‘may never fully recover’ from Petya attack
5 must-reads for supply chain leaders this week
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.